Optimising P2Y12 inhibition in real world clinical practice: clinical outcomes of prasugrel and ticagrelor.
28 August 2016 (13:15 - 13:35)
Organised by:
About the speaker
Leiden University Medical Center, Leiden (Netherlands (The))
3 More presentations in this session
Welcome & introduction: Potent P2Y12 receptor inhibition – What can we learn from clinical practice?
Professor K. Huber (Vienna, AT)
Professor K. Huber (Vienna, AT)
Access the full session
The Event
ESC Congress 2016
28 August 2016
13:15 CET
